» Articles » PMID: 37305720

Comprehensive Genetic Analyses of Childhood Acute Leukemia in Iraq Using Next-generation Sequencing

Abstract

Background: Molecular analyses in hematological malignancies provide insights about genetic makeup. Probable etiological factors in leukemogenesis could also be disclosed. Since genetic analyses are still primitive in Iraq, a country of repeated wars, we conceived of performing next-generation sequencing (NGS), to disclose the genomic landscape of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) among a cohort of Iraqi children.

Methods: Dried blood samples were collected from Iraqi children with ALL (n=55), or AML (n=11), and transferred to Japan where NGS was done. Whole-exome, whole-genome, and targeted gene sequencings were performed.

Results: Somatic point mutations and the copy number variations among Iraqi children with acute leukemia were comparable with those in other countries, and cytosine-to-thymine nucleotide alterations were dominant. Strikingly, was the most recurrent fusion gene (22.4%) in B-cell precursor ALL (B-ALL), and acute promyelocytic leukemia (AML-M3) was subtyped in 5 AML cases. Additionally, a high frequency of signaling pathway mutations was detected in children with B-ALL (38.8%), along with 3 AML cases that carried oncogenic .

Conclusions: Apart from disclosing the high frequency of , NGS confirmed our previous finding of recurrent mutations in Iraqi childhood acute leukemia. Our results suggest that the biology of Iraqi childhood acute leukemia is in part characteristic, where the war-aftermath environment or geography might play a role.

Citing Articles

Genetic Insights Into Leukemia Susceptibility in the Arab Population: A Scoping Review.

Algarni A Cureus. 2024; 16(8):e67421.

PMID: 39310620 PMC: 11415027. DOI: 10.7759/cureus.67421.

References
1.
Suzuki K, Okuno Y, Kawashima N, Muramatsu H, Okuno T, Wang X . MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents. J Clin Oncol. 2016; 34(28):3451-9. DOI: 10.1200/JCO.2016.66.5547. View

2.
Ratti S, Lonetti A, Follo M, Paganelli F, Martelli A, Chiarini F . B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?. Cancers (Basel). 2020; 12(12). PMC: 7760974. DOI: 10.3390/cancers12123498. View

3.
Zhang L, Samad A, Pombo-de-Oliveira M, Scelo G, Smith M, Feusner J . Global characteristics of childhood acute promyelocytic leukemia. Blood Rev. 2014; 29(2):101-25. PMC: 4379131. DOI: 10.1016/j.blre.2014.09.013. View

4.
Lin A, Cheng F, Chiang A, Luk C, Li R, Ling A . Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong. Pediatr Blood Cancer. 2018; 65(12):e27346. DOI: 10.1002/pbc.27346. View

5.
Yamamoto T, Isomura M, Xu Y, Liang J, Yagasaki H, Kamachi Y . PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia. Leuk Res. 2006; 30(9):1085-9. DOI: 10.1016/j.leukres.2006.02.004. View